Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Impax Pharmaceuticals

Division of Amneal Pharmaceuticals LLC

Latest From Impax Pharmaceuticals

Deal Watch: Valeant Sells Off iNova To Finance Debt-Reduction Efforts

While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.

Deals M & A

People In the News: Amicus, Catabasis, Astellas Add Reg/Policy Execs

Andrew Mulberg leaves US FDA for Amicus Therapeutics. Ipsen, Iroko, TapImmune make topside changes.

Appointments Europe

Impax Parkinson’s Therapy Suffers Manufacturing Setback During FDA Review

FDA dealt Impax Pharmaceuticals a “complete response” for its extended-release carbidopa/levodopa therapy for spasms suffered by Parkinson’s disease patients, rejecting the drug combo based on unresolved manufacturing issues at the firm’s Hayward, Calif., plant, though Impax has said it will manufacture the product, now called Rytary, exclusively at its Taiwan facility.

BioPharmaceutical United States

Deals Shaping The Medical Industry (03/2012)

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amneal Pharmaceuticals LLC
  • Senior Management
  • Michael Nestor, Pres.
    Suneel Gupta, PhD, CSO
    Shawn Fatholahi, VP, Sales & Mktg.
    David Paterson, PhD, VP, Bus. Dev.
  • Contact Info
  • Impax Pharmaceuticals
    Phone: (510) 240-6000
    31047 Genstar Rd.
    Hayward, CA 94544